Learn more at LeadIQ.com

Insights

Expansion Potential CG Oncology recently launched interim data from Phase III BOND-003 study, showing promising results in bladder cancer treatment. This success can open up opportunities for expansion into other urologic cancer indications.

Investor Interest With substantial investments from Biotechnology Value Fund and successful IPO raising $380M, CG Oncology's financial health and growth potential have attracted investor interest. This momentum can be leveraged to forge strategic partnerships and secure additional funding for future projects.

Competitive Positioning Being a late-stage clinical biopharmaceutical company with a focus on bladder cancer, CG Oncology is uniquely positioned among its competitors. Highlighting the innovative nature of cretostimogene grenadenorepvec can differentiate the company in a crowded market.

Technology Utilization CG Oncology employs a diverse tech stack including Google Analytics, Genesys, and MySQL. Leveraging advanced technologies can streamline operations, enhance data analytics for targeted sales strategies, and optimize customer engagement.

Key Personnel Impact The appointment of Vijay Kasturi as Chief Medical Officer signifies a strategic focus on medical expertise and leadership. Kasturi's experience can enhance credibility, drive future clinical developments, and establish key KOL relationships critical for sales success.

Similar companies to CG Oncology

CG Oncology Tech Stack

CG Oncology uses 8 technology products and services including Google Analytics, Genesys, MySQL, and more. Explore CG Oncology's tech stack below.

Google Analytics
Analytics
Genesys
Customer Experience Management
MySQL
Database
RSS
Miscellaneous
Priority Hints
Performance
SiteGround
Platform As A Service
ZURB Foundation
UI Frameworks
Apache HTTP Server
Web Servers

Media & News

CG Oncology's Email Address Formats

CG Oncology uses at least 1 format(s):

CG Oncology Email Formats	Example	Percentage
First.Last@cgoncology.com	John.Doe@cgoncology.com	48%
Last@cgoncology.com	Doe@cgoncology.com	3%
F.Last@cgoncology.com	J.Doe@cgoncology.com	1%
First.Last@cgoncology.com	John.Doe@cgoncology.com	48%

Frequently Asked Questions

Where is CG Oncology's headquarters located?

CG Oncology's main headquarters is located at 400 Spectrum Center Drive Suite 2040 Irvine, CA 92618 US. The company has employees across 4 continents, including North AmericaEuropeSouth America.

What is CG Oncology's phone number?

You can contact CG Oncology's main corporate office by phone at

+1-714-884-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CG Oncology's stock symbol?

CG Oncology is a publicly traded company; the company's stock symbol is CGON.

What is CG Oncology's official website and social media links?

CG Oncology's official website is cgoncology.com and has social profiles on LinkedIn.

How much revenue does CG Oncology generate?

As of September 2024, CG Oncology's annual revenue reached $35M.

What is CG Oncology's SIC code NAICS code?

CG Oncology's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CG Oncology have currently?

As of September 2024, CG Oncology has approximately 115 employees across 4 continents, including North AmericaEuropeSouth America. Key team members include Chief Financial Officer: C. R.Chief Medical Officer: V. K.Chief Regulatory Officer: U. F.. Explore CG Oncology's employee directory with LeadIQ.

What industry does CG Oncology belong to?

CG Oncology operates in the Biotechnology Research industry.

What technology does CG Oncology use?

CG Oncology's tech stack includes Google AnalyticsGenesysMySQLRSSPriority HintsSiteGroundZURB FoundationApache HTTP Server.

What is CG Oncology's email format?

CG Oncology's email format typically follows the pattern of . Find more CG Oncology email formats with LeadIQ.

How much funding has CG Oncology raised to date?

As of September 2024, CG Oncology has raised $105M in funding. The last funding round occurred on Aug 02, 2023 for $105M.

When was CG Oncology founded?

CG Oncology was founded in 2010.

CG Oncology

CG Oncology

Biotechnology ResearchCalifornia, United States51-200 Employees

CG Oncology, Inc. (Nasdaq: CGON), is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative oncolytic immunotherapies to live with dignity and have an enhanced quality of life.

Our lead candidate, cretostimogene grenadenorepvec, is an intravesically delivered oncolytic immunotherapy agent in a Phase 3 trial for the treatment of BCG-unresponsive non-muscle invasive bladder cancer. Cretostimogene grenadenorepvec is also in a Phase 2 study in combination with KEYTRUDA® (pembrolizumab) in the same indication. Other types of bladder cancer are being evaluated with cretostimogene grenadenorepvec in combination with OPDIVO® (nivolumab).

Company Overview

Headquarters: 400 Spectrum Center Drive Suite 2040 Irvine, CA 92618 US
Phone number: ✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-714-884-****
Website: cgoncology.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: CGON
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2010
Employees: 51-200

Media & News

Funding & Financials

$105M
CG Oncology has raised a total of $105M of funding over 7 rounds. Their latest funding round was raised on Aug 02, 2023 in the amount of $105M.
$10M$50M
CG Oncology's revenue is in the range of $10M$50M

Funding & Financials

$105M
CG Oncology has raised a total of $105M of funding over 7 rounds. Their latest funding round was raised on Aug 02, 2023 in the amount of $105M.
$10M$50M
CG Oncology's revenue is in the range of $10M$50M

Company Leadership

C. R.
Chief Financial Officer
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
V. K.
Chief Medical Officer
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
U. F.
Chief Regulatory Officer
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. L.
Chief Of Staff
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. M.
Vice President Clinical Operations
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

G. R.
Cto
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. S.
Senior Executive Assistant To The President And Chief Operating Officer
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
U. F.
Chief Regulatory Officer
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. M.
Svp Strategy And Operations
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. H.
Vp Of Marketing
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CG Oncology and Millions of Other Companies
Sign up for full access to CG Oncology information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.